Transformational cell therapies for patients with serious diseases

News

Featured News

Louisville’s Koligo Therapeutics aims to scale up with $2 million in new funding

Local doctors are performing islet transplants

Surgeons with Jewish Hospital/University of Louisville/University of Louisville Physicians Perform First Islet Cell Auto-transplantation Procedures in Kentucky

Adelaide doctors perform operation to have boy’s liver produce insulin to avoid diabetes

Press Releases

Koligo Therapeutics to Participate in Maxim Group and M-Vest COVID-19 Virtual Conference Series (May 22nd, 2020)

Koligo Therapeutics to develop personalized cell therapy for the treatment of COVID-19 (May 21st, 2020)

KYSLECEL™ with 24-hour expiration time improves access to chronic pancreatitis treatment across the United States (July 16th, 2019)

Vanguard Surgical accepting referrals for TP-IAT with KYSLECEL™ to treat pancreatitis (July 18th, 2018)

Koligo introduces KYSLECEL™ autologous cell therapy product.

Kyslecel personalized cell therapy for chronic pancreatitis. Because pain should not define your life.